Investigating how HIV-1 capsid affects the immune response to the virus
Role of HIV-1 capsid in innate sensing of viral nucleic acids
This study is looking at how a specific part of the HIV virus helps the immune system notice the virus, with the goal of finding new ways to create treatments that can better help your body fight HIV.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-10886816 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of the HIV-1 capsid protein in how the immune system detects viral nucleic acids. By studying the structural properties of the capsid and its interactions during the viral replication cycle, researchers aim to identify new targets for antiretroviral drugs. The approach involves analyzing how changes in the capsid can influence the formation of viral particles and the immune response. This could lead to the development of innovative therapies that enhance the body's ability to fight HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who may benefit from new antiretroviral therapies.
Not a fit: Patients who are not infected with HIV or those who have already achieved viral suppression with current therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve the effectiveness of HIV therapies and potentially reduce drug resistance.
How similar studies have performed: Previous research has shown promise in targeting the HIV-1 capsid for drug development, indicating that this approach could be effective.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Eschbach, Jenna — Washington University
- Study coordinator: Eschbach, Jenna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.